Samuel Ajizian

CMO Patient Monitoring VP, Clinical Research & Medical Science Patient Monitoring & Respiratory Interventions

Samuel Ajizian, MD, FAAP, FCCM, CPPS is a board-certified Pediatric Intensivist with over 20 years of clinical practice in the Pediatric ICU. Dr. Ajizian received his MD from the University of Southern California and completed pediatric residency and Chief Residency at Children’s Hospital Los Angeles. He then entered the U.S. Air Force where he served 3 years on active duty as a pediatrician and Flight Surgeon in F-16s. He then completed pediatric critical care fellowship at Le Bonheur Children’s Hospital, University of Tennessee.

Dr. Ajizian joined Medtronic in 2015. His first role was Vice President, Medical Affairs for the Patient Monitoring and Recovery business unit. In this capacity, he oversaw safety issues for devices in the field, and provided medical direction cross functionally for product development, research, education, and the engagement of key opinion leaders globally. In 2018, he assumed direction of the MITG Medical Safety Office. In this role, he oversaw patient safety investigations, Issue Impact Assessments, and management of high-level safety and regulatory issues supporting from the medical side. He is co-chair of the Medtronic Medical Safety Council and works across the enterprise to help drive Patient Safety excellence.

In 2020, Dr. Ajizian became interim director of the MITG Scientific Communications team. In this role, he oversaw the production of key compliance related deliverables to our stakeholders including Clinical Evaluation Reports. In late 2020, Dr. Ajizian became the CMO for Patient Monitoring, and VP for Clinical Research & Medical Science for Patient Monitoring and Respiratory Interventions. In these roles, he helps advise the OU on business strategy, including BD&L ventures, as well as research, publications, safety, and education across both OUs.